67°

Topics

Vivus Inc.
FDA shoots down another weight loss drug [Updated]
FDA shoots down another weight loss drug [Updated]

The FDA has told the makers of the proposed weight-loss drug Lorcaserin that it will not at this time approve the marketing of  the medication, citing concerns about its marginal effectiveness and about cancers that occurred at higher-than-usual rates in animal studies. [Updated Oct. 25, 10:35 a.m. An earlier version of this article said cancers occurred at higher-than-usual-rates during clinical trials.]The FDA's decision comes just two weeks after the makers of the prescription diet-pill Meridia pulled it from the U.S. and Canadian markets at the request of the FDA. It is the first signal of how the U.S. drug agency will deliberate on a trio of new weight-loss drugs proposed for the U.S....

Loading